These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 7159214

  • 21. Recent changes in influenza vaccination recommendations, 2007.
    Zimmerman RK.
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S12-7, C1. PubMed ID: 17270107
    [Abstract] [Full Text] [Related]

  • 22. Epidemiological evaluation of the protection conferred by the Nivgrip vaccine against influenza caused by the A(H1N1) virus.
    Teodorovici G, Ivan A, Petrescu A, Mihail A, Cajal N.
    Virologie; 1982 Feb; 33(4):279-82. PubMed ID: 7164342
    [No Abstract] [Full Text] [Related]

  • 23. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Oct 09; 58(39):1100-1. PubMed ID: 19816398
    [Abstract] [Full Text] [Related]

  • 24. Prevention and control of influenza.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 May 23; 35(20):317-26, 331. PubMed ID: 3010071
    [No Abstract] [Full Text] [Related]

  • 25. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF, Brooks WA, Goswami D, Lagos R, Borja-Tabora C, Lanata CF, Londoño JA, Lum LC, Rappaport R, Razmpour A, Walker RE, Gruber WC, Forrest BD.
    Vaccine; 2009 Sep 04; 27(40):5472-9. PubMed ID: 19616493
    [Abstract] [Full Text] [Related]

  • 26. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group.
    Pediatr Infect Dis J; 2006 Oct 04; 25(10):870-9. PubMed ID: 17006279
    [Abstract] [Full Text] [Related]

  • 27. [Use of the elution inhibition reaction for detecting antineuraminidase antibodies in the sera of persons inoculated with inactivated influenza vaccine].
    Briantseva EA.
    Tr Inst Im Pastera; 1982 Oct 04; 59():59-62. PubMed ID: 6764988
    [No Abstract] [Full Text] [Related]

  • 28. Influenza vaccines 1983-1984. Recommendation of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1983 Oct 04; 99(4):497-9. PubMed ID: 6625385
    [Abstract] [Full Text] [Related]

  • 29. Recent changes in influenza epidemiology and vaccination recommendations.
    Zimmerman RK.
    J Fam Pract; 2005 Jan 04; 54(1 Suppl):S1-8. PubMed ID: 15623391
    [Abstract] [Full Text] [Related]

  • 30. Intranasal influenzavirus vaccine in children.
    Edwards KM, Dupont WD.
    N Engl J Med; 1998 Sep 24; 339(13):922; author reply 922-3. PubMed ID: 9750091
    [No Abstract] [Full Text] [Related]

  • 31. [Epidemiological surveillance of influenza. Principles, means, possibilities].
    Raşcu D.
    Bacteriol Virusol Parazitol Epidemiol; 2007 Sep 24; 52(3-4):163-80. PubMed ID: 19326730
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of an adsorbed trivalent split influenza vaccine administered by intradermal route.
    Niculescu IT, Zilişteanu E, Alexandrescu V, Maţepiuc M, Creţescu L, Ionescu N, Molnar G, Răcăşan R, Mogoş A.
    Arch Roum Pathol Exp Microbiol; 1981 Sep 24; 40(1):67-70. PubMed ID: 7185350
    [No Abstract] [Full Text] [Related]

  • 33. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1990-1991 season.
    Can Dis Wkly Rep; 1990 Jun 23; 16(25):117-21. PubMed ID: 2397526
    [No Abstract] [Full Text] [Related]

  • 34. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB.
    J Infect Dis; 2001 Jan 15; 183(2):329-332. PubMed ID: 11110645
    [Abstract] [Full Text] [Related]

  • 35. ACIP releases recommendations for use of live, attenuated influenza vaccine.
    Ressel GW, ACIP of the Centers for Disease Control and Prevention.
    Am Fam Physician; 2003 Dec 01; 68(11):2275-6. PubMed ID: 14677671
    [No Abstract] [Full Text] [Related]

  • 36. Monovalent influenza A(H1N1) vaccine, 1986-1987.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Aug 15; 35(32):517-21. PubMed ID: 3090424
    [No Abstract] [Full Text] [Related]

  • 37. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct 06; 50(1296):77-9. PubMed ID: 18833032
    [Abstract] [Full Text] [Related]

  • 38. [Results of a 3-year survey of persons inoculated with inactivated influenza vaccine (IIV). I. An evaluation of its reactogenic peoperties, safety and epidemiological effectiveness].
    Mukhina LP, Kozlova NA, Rykushin IuP, Fridman EA, Bichurina MA.
    Tr Inst Im Pastera; 1979 Oct 06; 52():65-71. PubMed ID: 162088
    [No Abstract] [Full Text] [Related]

  • 39. [Methodological approach to evaluating the vaccinal prevention of influenza as an epidemic control measure].
    Rykushin IuP, Mukhina LP.
    Tr Inst Im Pastera; 1982 Oct 06; 59():55-9. PubMed ID: 6228045
    [No Abstract] [Full Text] [Related]

  • 40. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Dec 11; 58(48):1351-6. PubMed ID: 20010511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.